One company that constantly finds its name in the spotlight is Tesla (NASDAQ: TSLA). The company's CEO, entrepreneur Elon Musk, is equal parts entertaining and, at times, pretty jarring. To be blunt, 2024 hasn't been kind to Tesla shareholders. While most of the company's "Magnificent Seven" peers have generated nice share price gains so far this year, Tesla shares are down about 23%.
Open FlipOne of the best things about investing on Wall Street is there's a strategy that can satisfy everyone. With thousands of publicly traded companies and exchange-traded funds (ETFs) to choose from, pathways exist for investors of varying risk tolerances to grow their wealth over time.But among these seemingly countless plans of action, buying and holding high-quality dividend stocks is tough.
Open FlipPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its stock in serious bargain territory. Speaking to this point, Pfizer's stock trades at around 11 times forward earnings. On the other hand, its big-pharma peer group averages 17 on this key valuation metric.
Open Flip